Faruqi and Faruqui, LLP Logo
Share this page

Synovis Life Technologies, Inc. (SYNO)



Faruqi & Faruqi, LLP Announces Investigation of Synovis Life Technologies, Inc. (SYNO)

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (NASDAQ: SYNO) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Baxter International, Inc. in an all-cash deal valued at about $325 million. Under the terms of the proposed transaction, Synovis stockholders will receive $28.00 in cash for each share of Synovis common stock they own.

Whether Synovis’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Synovis’s shares and by how much this proposed transaction undervalues the Company to the detriment of Synovis’s shareholders are the key focus of this investigation.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Synovis Life Technologies, Inc. (SYNO)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Juan E. Monteverde
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.